Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42)

The summary for the Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42): This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop a product, process or service for commercialization with the aim of reducing disparities in healthcare access and health outcomes in one or more NIH-defined health disparity population group(s). Appropriate technologies should be effective, affordable, culturally acceptable, and deliverable to racial/ethnic minorities, low-income and rural populations.

Federal Grant Title:	Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-MD-17-002
Type of Funding:	Grant
CFDA Numbers:	93.307
CFDA Descriptions:	Information not provided
Current Application Deadline:	February 22nd, 2017
Original Application Deadline:	February 22nd, 2017
Posted Date:	December 12th, 2016
Creation Date:	December 12th, 2016
Archive Date:	March 25th, 2017
Total Program Funding:	$1,000,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	December 12th, 2016

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/RFA-MD-17-002.html
Grant Announcement Contact: NIH OER Webmaster
[email protected]

If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants: • Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experienc...; • Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparitie...; • Coordinating Center to Support Multi-Sectoral Preventive Interventions that Address Social...; • Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional); • Unveiling Health and Healthcare Disparities in Non-Communicable and Chronic Diseases in La...; • Excellence in Partnerships for Community Outreach, Research on Health Disparities and Trai...; • Excellence in Partnerships for Community Outreach, Research on Health Disparities and Trai...; • Excellence in Partnerships for Community Outreach, Research on Health Disparities and Trai...
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...